Mitigating Risks of Compounded Drugs Through Surveillance FDA Here's your Monthly Dose my supplement spotlight on what's trending, what's promising, and what actually holds up under scientific scrutiny. This month: BPC 157. Often called the injury recovery peptide, BPC 157 has FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York What are peptides? The treatments promising weight loss and better skin, explained Vox The Emerging Risk of Peptides in Supplements LegitScript